New York, NY -- (SBWIRE) -- 04/20/2021 -- The biobanks market is projected to grow at a rate of 4.3% in terms of value, from USD 57.17 Billion in 2019 to reach USD 80.37 Billion by 2027. Rising demand for stem cell preservation of newborns is instrumental in fuelling the growth of the market. Stem cells have the capability of discerning and regenerating various kinds of cells in the human body. These cells possess the potential to cure life-threatening diseases such as oncological and blood-related disorders. Cord blood stem cells find application in the treatment of more than 80 blood-related ailments, such as Sickle Cell Disease. It is projected that over 27 million babies across the globe are born with some kind of blood disorder. As per the World Health Organization, in 2008, 100,000 children were found to e suffering from thalassemia in India. Constant researches are being carried out all over the world to study the usage of umbilical cord blood and tissue stem cell for the treatment of fatal diseases.

Growing technological advancements is likely to boost the market demand in the upcoming years. Process automation, robotics, data analytics, and other swiftly evolving technological advances are pushing the revolution of biobanks, and biospecimen science. The evolution of biobanks from a collection of frozen specimens to the virtual biobanks offers countries and its economic and healthcare systems a massive potential for transformation. The instantaneous emphasis of rapidly developing biobanks appears to be on the understanding of diseases, and drug discovery, among others.

Key participants include Becton, Dickinson, and Company, Merck KGaA, Thermo Fisher Scientific Inc., Tecan Trading AG, Panasonic Healthcare Holdings Co. Ltd., Hamilton Company, VWR Corporation, Brooks Automation Inc., Promega Corporation, and Chart Industries Inc., among others.

To Get Sample Copy of Report visit @ https://www.reportsanddata.com/sample-enquiry-form/3083

COVID-19 Impact
COVID-19 pandemic is not the first of its kind that the biobanking industry has had to bend to a new actuality and innovative practices owing to the emergence of a novel contagious disease. Biobanking is an important tool and resource of public health organizations and healthcare service providers to combat COVID-19. A continuous rise in global cases, along with the disastrous loss of life, biobanks carry on to handle their roles in the collection of the patient sample, it's processing, and analysis, which are crucial factors in controlling new infectious diseases. The Centers for Disease Control and Prevention (CDC) has issued guidelines for managing COVID-19 samples that have helped as a model for biobanks across the globe.

For the purpose of this report, Reports and Data have segmented the global biobanks market on the basis of type, storage type, product, specimen type, application, and region:

Type Outlook (Revenue, USD Million; 2017-2027)

Disease-Oriented Biobanks
Population-Based Biobanks

Storage Type Outlook (Revenue, USD Million; 2017-2027)

Manual Storage
Automated Storage

Product Outlook (Revenue, USD Million; 2017-2027)

Equipment
Consumables
Software
Services
Specimen Type Outlook (Revenue, USD Million; 2017-2027)

Human Organs
Human Tissues
Stem Cells
Others

Application Outlook (Revenue, USD Million; 2017-2027)

Drug Discovery & Clinical Research
Therapeutics
Clinical Diagnostics
Others

Regional Outlook (Revenue, USD Million; 2017-2027)

North America
Europe
Asia Pacific
Latin America
MEA

To get a Discount on the Biobanks Market Report, Click @ https://www.reportsanddata.com/discount-enquiry-form/3083

Further key findings from the report suggest

By type, population-based biobanks are likely to grow at a rate of 3.7% in the forecast period. Population biobanks emphasize identifying the nation or geographic region of origin of healthy donors from DNA analysis and identify specific ethnic cohorts for enrollment for the purpose of the study. The significance of population-based biobanks is that they combine genomics with public health research by enabling population-selective cohort studies.

By storage type, the automated storage type is likely to grow at a faster rate of 5.1% in the forecast period. Automated storage provides the likelihood of defragmentation and, therefore, efficient deployment and optimization of storage space. This is of utmost importance owing to the presence of several dynamic processes in biobanks. At present, automated storage types provide various combinations of temperature handling and storage.

By product type, equipment contributed to the largest market share in 2019. The high demand for equipment is owing to the growing demand for storing of biosamples in biobanks.

By specimen type, human tissues accounted for a significant market share in 2019 and are likely to grow at a rate of 4.5% in the forecast period. Human tissue is vital for advancement in knowledge of disease mechanisms and pathways. Research deploying human tissue can progress a fundamental understanding of human biology, aid develops disease diagnosis methods, treatment protocols, and future therapies.

By application, therapeutics held the second-largest market share in 2019 and is likely to grow at a rate of 4.4% in the forecast period. Biobanks support health care enabling novel therapeutic strategies. Disease-oriented biobanks were formed to encourage the study of human ailment pathogenesis to recognize likely therapeutic strategy.

The market in the Asia Pacific region is likely to grow at the fastest rate of 5.3% in the forecast period, owing to the growing healthcare investments in nations including China and South Korea, among other factors.
In January 2018, STEMCELL Technologies Inc. launched two product lines for organoid research to allow scientists to produce robust models for studying human illness in the lab.

Browse Full Report @ https://www.reportsanddata.com/report-detail/biobanks-market

Table of Content:

Chapter 1. Market Synopsis
1.1. Market Definition
1.2. Research Scope & Premise
1.3. Methodology
1.4. Market Estimation Technique
Chapter 2. Executive Summary
2.1. Summary Snapshot, 2019-2027
Chapter 3. Indicative Metrics
Chapter 4. Biobanks Segmentation & Impact Analysis
4.1. Biobanks Material Segmentation Analysis
4.2. Industrial Outlook
4.2.1. Market indicators analysis
4.2.2. Market drivers analysis
4.2.2.1. Increasing incidence of chronic diseases
4.2.2.2. Increasing emphasis on genetic testing
4.2.2.3. Rising inclination for stem cell preservation of newborns
4.2.2.4. Advancement in Technology
4.2.3. Market restraints analysis
4.2.3.1. Limited access to biospecimens
4.2.3.2. Cost-prohibitive automation process
4.3. Technological Insights
4.4. Regulatory Framework
4.5. ETOP Analysis
4.6. Porter's Five Forces Analysis
4.7. Competitive Metric Space Analysis
4.8. Price trend Analysis
4.9. Customer Mapping
4.10. Covid-19 Impact Analysis
4.11. Global Recession Influence

Continued…

Request customization of the report @ https://www.reportsanddata.com/request-customization-form/3083

Thank you for reading our report. To receive further information on the report or to enquire about its customization, please get in touch with us and get your report tailored according to your needs.

About Reports and Data
Reports and Data is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target and analyze consumer behavior shifts across demographics, across industries and help client's make a smarter business decision. We offer market intelligence studies ensuring relevant and fact-based research across a multiple industries including Healthcare, Technology, Chemicals, Power and Energy. We consistently update our research offerings to ensure our clients are aware about the latest trends existent in the market.

Contact Us:
John W
Head of Business Development
40 Wall St. 28th floor New York City
NY 10005 United States
Direct Line: +1-212-710-1370